The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim results of viagenpumatucel-L (HS-110) plus nivolumab in previously treated patients (pts) with advanced non-small cell lung cancer (NSCLC) in two treatment settings.
 
Roger B. Cohen
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca; Cantargia AB; Genocea Biosciences; Heat Biologics; Innate Pharma; Xencor
Research Funding - AstraZeneca (Inst); Celldex (Inst); Genocea Biosciences (Inst); Heat Biologics (Inst); Innate Pharma (Inst); Kyn therapeutics (Inst); Merck (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Genocea Biosciences; Innate Pharma
 
George Earl Peoples
Employment - Cancer Insight; Orbis Health Solutions
Leadership - Cancer Insight; Orbis Health Solutions
Stock and Other Ownership Interests - Cancer Insight; Orbis Health Solutions; Rapamycin Holdings
Consulting or Advisory Role - Abexxa Biologics; Heat Biologics; Pelican Therapeutics; Rapamycin Holdings
Research Funding - Genentech; Orbis Health Solutions; Sellas Life Sciences
Patents, Royalties, Other Intellectual Property - Royalties
Travel, Accommodations, Expenses - Cancer Insight; Heat Biologics; Orbis Health Solutions; Sellas Life Sciences
 
Toana Kawashima
Stock and Other Ownership Interests - Philips Healthcare
 
Bill Arana
Employment - Heat Biologics
Stock and Other Ownership Interests - Heat Biologics
 
Xiaoxing Cui
Employment - Heat Biologics
Stock and Other Ownership Interests - Heat Biologics
Travel, Accommodations, Expenses - Heat Biologics
 
Lyudmila Bazhenova
Stock and Other Ownership Interests - Epic Sciences
Consulting or Advisory Role - AstraZeneca; Bayer; BeyondSpring Pharmaceuticals; Blueprint Medicines; BMSi; Boehringer Ingelheim; Daichi; G1 Therapeutics; Genentech/Roche; Johnson and Johnson; Merck; neuvogen; Novartis; Regeneron; Takeda
Research Funding - BeyondSpring Pharmaceuticals
 
Rachel E. Sanborn
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi Sankyo/Lilly; EMD Serono; Genentech/Roche; Janssen Oncology; Macrogenics
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck
Travel, Accommodations, Expenses - AstraZeneca
 
Wael A. Harb
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cota Healthcare; G1 Therapeutics; Genentech; Inivata; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer; Viosera Therapeutics; Xencor
Research Funding - Altor BioScience (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Heat Biologics (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst); WindMIL (Inst)
 
Daniel Morgensztern
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; G1 Therapeutics; Gilead Sciences; PharmaMar; Takeda
Research Funding - Abbvie (Inst); Altum Pharmaceuticals (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Baxter (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EpicentRx (Inst); Heat Biologics (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Surface Oncology (Inst)